Medicare Enrolled
Dr. Allan Perel, M.D.
Neurology · Staten Island, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Perel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Perel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Perel
Dr. Allan Perel is a neurology specialist in Staten Island, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Perel performed 19,139 Medicare services across 3,299 unique beneficiaries.
Between the years covered by Open Payments, Dr. Perel received a total of $1,839,871 from 85 pharmaceutical and/or device companies across 3536 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Perel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 5% volume in NY
$1,839,871 industry payments
Medicare Practice Summary
Medicare Utilization ↗19,139
Medicare services
Top 5% in NY for neurology
3,299
Unique beneficiaries
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~957 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
14,795 | $5 | $8 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
810 | $113 | $350 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
678 | $90 | $198 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
595 | $59 | $300 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
426 | $146 | $450 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
274 | $175 | $425 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
178 | $159 | $425 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
170 | $114 | $300 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
169 | $32 | $75 |
| Vestibular function test with thermal irrigation A test that assesses balance by irrigating both ears with warm and cool fluids to evaluate inner ear function. |
115 | $36 | $100 |
| Balance testing with recording A procedure to evaluate balance function by recording the results during testing. |
115 | $97 | $222 |
| Vestibular function test using rotating chair This test evaluates eye movement and balance function by having the patient sit in a rotating chair. It helps assess how the inner ear and brain coordinate to maintain stability. |
115 | $121 | $238 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
108 | $72 | $300 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
101 | $0 | $12 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
86 | $124 | $350 |
| Psychological test administration, each additional 30 minutes A technician administers psychological or neuropsychological testing. This code covers each additional 30-minute increment of administration time. |
67 | $33 | $75 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
65 | $158 | $350 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
60 | $264 | $700 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
59 | $120 | $400 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
56 | $259 | $460 |
| New patient office visit, complex (60-74 min) | 44 | $195 | $500 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
42 | $191 | $525 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
11 | $109 | $255 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.0% high complexity
79.4% medium
19.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,839,871
Total received (2018-2024)
Avg $262,839/year across 7 years
Top 0% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
85
Companies
3,536
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,811,335 (98.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,933 (1.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,603 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$171,177
2023
$196,327
2022
$297,836
2021
$229,468
2020
$238,514
2019
$345,074
2018
$361,475
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
TG Therapeutics, Inc.
$49,053
E.R. Squibb & Sons, L.L.C.
$20,758
EMD Serono, Inc.
$20,043
ABBVIE INC.
$13,817
Biogen, Inc.
$11,698
Eisai Inc.
$10,298
Teva Pharmaceuticals USA, Inc.
$9,968
SCILEX PHARMACEUTICALS INC.
$8,234
Kyowa Kirin, Inc.
$8,194
Vanda Pharmaceuticals Inc.
$7,634
Amgen Inc.
$7,342
PFIZER INC.
$486
Celgene Corporation
$437
Neurocrine Biosciences, Inc.
$379
Genentech, Inc.
$354
Genentech USA, Inc.
$319
ANI Pharmaceuticals, Inc.
$261
ARGENX US, INC.
$241
Alexion Pharmaceuticals, Inc.
$188
UCB, Inc.
$180
ACADIA Pharmaceuticals Inc
$173
Sumitomo Pharma America, Inc.
$162
Lilly USA, LLC
$154
AstraZeneca Pharmaceuticals LP
$125
Ipsen Biopharmaceuticals, Inc
$108
Boston Scientific Corporation
$101
Lundbeck LLC
$100
SK Life Science, Inc.
$94
Corium, LLC
$71
Otsuka Pharmaceutical Development & Commercialization, Inc.
$69
Mallinckrodt Hospital Products Inc.
$59
Brainsway USA INC
$50
Octapharma USA, Inc.
$25
Top 3 companies account for 52.5% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$350,676
EMD Serono, Inc.
$186,725
Teva Pharmaceuticals USA, Inc.
$169,496
E.R. Squibb & Sons, L.L.C.
$135,039
GENZYME CORPORATION
$108,533
Genentech USA, Inc.
$82,192
ABBVIE INC.
$76,584
Amgen Inc.
$70,243
Neurocrine Biosciences, Inc.
$55,641
Alexion Pharmaceuticals, Inc.
$55,508
Kyowa Kirin, Inc.
$49,368
TG Therapeutics, Inc.
$49,120
Horizon Therapeutics plc
$44,032
Allergan, Inc.
$40,771
Celgene Corporation
$36,618
Mallinckrodt LLC
$31,202
AbbVie Inc.
$29,646
Acorda Therapeutics, Inc
$25,664
Mallinckrodt Hospital Products Inc.
$23,910
Eisai Inc.
$23,132
Biohaven Pharmaceuticals, Inc.
$22,948
Biohaven Pharmaceutical Holding Company Ltd.
$22,534
Mallinckrodt Enterprises LLC
$22,104
Janssen Pharmaceuticals, Inc
$20,332
TG THERAPEUTICS, INC.
$16,176
Lilly USA, LLC
$15,100
Neurocrine BioSciences, Inc.
$14,600
Novartis Pharmaceuticals Corporation
$9,483
SCILEX PHARMACEUTICALS INC.
$8,330
Vanda Pharmaceuticals Inc.
$7,634
Corium, LLC
$7,514
BANNER LIFE SCIENCES, LLC
$6,343
PFIZER INC.
$5,078
Assertio Therapeutics, Inc.
$5,066
Banner Life Sciences, LLC
$2,549
ACADIA Pharmaceuticals Inc
$1,239
UCB, Inc.
$1,033
Genentech, Inc.
$1,013
ARGENX US, INC.
$846
SK Life Science, Inc.
$701
ANI Pharmaceuticals, Inc.
$455
IMPEL PHARMACEUTICALS INC.
$439
Scilex Pharmaceuticals Inc.
$376
Sunovion Pharmaceuticals Inc.
$311
Kowa Pharmaceuticals America, Inc.
$273
Lundbeck LLC
$269
Exeltis, USA Inc.
$253
Sumitomo Pharma America, Inc.
$243
Avanir Pharmaceuticals, Inc.
$200
US WorldMeds, LLC
$180
AbbVie, Inc.
$162
Almatica Pharma LLC
$153
Supernus Pharmaceuticals, Inc.
$137
AstraZeneca Pharmaceuticals LP
$125
Evofem Biosciences, Inc.
$125
Ipsen Biopharmaceuticals, Inc
$124
Boston Scientific Corporation
$114
Greenwich Biosciences, Inc.
$110
EISAI INC.
$97
Neurelis, Inc.
$87
Janssen Scientific Affairs, LLC
$82
Brainsway USA INC
$81
Stryker Corporation
$81
Otsuka Pharmaceutical Development & Commercialization, Inc.
$69
Bausch Health US, LLC
$60
Grifols USA, LLC
$55
Allergan Inc.
$50
GE Healthcare
$48
Avion Pharmaceuticals
$46
Amneal Pharmaceuticals LLC
$43
GE HEALTHCARE
$43
Otsuka America Pharmaceutical, Inc.
$31
Axsome Therapeutics, Inc.
$26
Octapharma USA, Inc.
$25
Abbott Laboratories
$21
Merz North America, Inc.
$18
Merck Sharp & Dohme Corporation
$17
ARBOR PHARMACEUTICALS, INC.
$16
LivaNova USA, Inc.
$16
Aprecia Pharmaceuticals, LLC
$15
UPSHER-SMITH LABORATORIES LLC
$15
Bayer HealthCare Pharmaceuticals Inc.
$15
Collegium Pharmaceutical, Inc.
$14
Akcea Therapeutics, Inc.
$14
Adamas Pharmaceuticals, Inc.
$13
Top 3 companies account for 38.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · Azstarys · BAFIERTAM · BELSOMRA · BOTOX · BRIUMVI · Betaseron · Brainsway Deep TMS · Brainsway Deep TMS System · Briviact · CAMBIA · COPAXONE · Cambia · Cenobamate · DUEXIS · Dhivy · Duopa · Dysport · ELYXYB - CELECOXIB · ELYXYB - celecoxib · EMGALITY · ES2 · Epidiolex · Fycompa · GENERAL PAIN MANAGEMENT · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gralise · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KISUNLA · KYNMOBI · LEMTRADA · LEQEMBI · LYRICA · Leqembi · Livalo · MAVENCLAD · MIGRANAL · MS DISEASE STATE · MYOBLOC · Mavenclad · NAMZARIC · NAPRELAN · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · OCREVUS · ONGENTYS · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · Ozanimod · PANZYGA · PLEGRIDY · PONVORY · PURIFIED CORTROPHIN GEL · Phexxi · Ponvory · QELBREE · QULIPTA · REXULTI · RYTARY · Rebif · SEGLENTIS · SOLIRIS · SPINRAZA · Seglentis · Soliris · Spritam · Sunosi · TECFIDERA · TEGSEDI · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · Tysabri · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS - Sentiva · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · XELJANZ · XEOMIN · Xadago · ZEPOSIA · ZINBRYTA · ZTLido · Zinbryta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (98%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for neurology in NY.
Geographic Context
Neurologists within 10 mi
1,142
Per 100K population
231.8
County median income
$98,290
Nearest hospital
STATEN ISLAND UNIVERSITY HOSPITAL
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Perel is a mixed practice specialist, with above-average Medicare volume (top 5% in NY), with speaking/promotional industry engagement in the top 0% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Perel experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Perel performed 14,795 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Perel receive payments from pharmaceutical companies?
Yes. Dr. Perel received a total of $1,839,871 from 85 companies across 3,536 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Perel's costs compare to other neurologists in Staten Island?
Dr. Perel's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Perel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Staten Island
Browse neurologists in Staten Island ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology